Cargando…
Novel Strategies against Cancer: Dexibuprofen-Loaded Nanostructured Lipid Carriers
The aim of this work was to design innovative nanostructured lipid carriers (NLCs) for the delivery of dexibuprofen (DXI) as an antiproliferative therapy against tumoral processes, and overcome its side effects. DXI-NLC samples were prepared with beeswax, Miglyol 812 and Tween 80 using high-pressure...
Autores principales: | Thiruchenthooran, Vaikunthavasan, Świtalska, Marta, Bonilla, Lorena, Espina, Marta, García, Maria Luisa, Wietrzyk, Joanna, Sánchez-López, Elena, Gliszczyńska, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570096/ https://www.ncbi.nlm.nih.gov/pubmed/36232614 http://dx.doi.org/10.3390/ijms231911310 |
Ejemplares similares
-
Dually Active Apigenin-Loaded Nanostructured Lipid Carriers for Cancer Treatment
por: Bonilla-Vidal, Lorena, et al.
Publicado: (2023) -
Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy
por: Esteruelas, Gerard, et al.
Publicado: (2022) -
Perspectives of the Application of Non-Steroidal Anti-Inflammatory Drugs in Cancer Therapy: Attempts to Overcome Their Unfavorable Side Effects
por: Thiruchenthooran, Vaikunthavasan, et al.
Publicado: (2023) -
Dexibuprofen Therapeutic Advances: Prodrugs and Nanotechnological Formulations
por: Gliszczyńska, Anna, et al.
Publicado: (2021) -
Riluzole-Loaded Nanostructured Lipid Carriers for Hyperproliferative Skin Diseases
por: Llorente, Xavier, et al.
Publicado: (2023)